Literature DB >> 12088407

Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease.

Raphael B Stricker1, Joseph Burrascano, Edward Winger.   

Abstract

Lyme disease is a tickborne illness caused by the spirochete Borrelia burgdorferi. In a previous report we described a decrease in the CD57 lymphocyte subset in patients with chronic Lyme disease. We have now identified a patient with chronic relapsing and remitting symptoms of Lyme disease who had decreased levels of CD57 lymphocytes over 10 years. This observation represents the longest duration of an immunologic abnormality ever documented in chronic Lyme disease. The CD57 lymphocyte subset appears to be a useful marker of longterm infection with the Lyme disease spirochete.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088407

Source DB:  PubMed          Journal:  Ann Agric Environ Med        ISSN: 1232-1966            Impact factor:   1.447


  9 in total

Review 1.  CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease.

Authors:  Marius Strioga; Vita Pasukoniene; Dainius Characiejus
Journal:  Immunology       Date:  2011-06-29       Impact factor: 7.397

Review 2.  Chronic Lyme disease.

Authors:  Paul M Lantos
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

3.  A selective antibiotic for Lyme disease.

Authors:  Nadja Leimer; Xiaoqian Wu; Yu Imai; Madeleine Morrissette; Norman Pitt; Quentin Favre-Godal; Akira Iinishi; Samta Jain; Mariaelena Caboni; Inga V Leus; Vincent Bonifay; Samantha Niles; Rachel Bargabos; Meghan Ghiglieri; Rachel Corsetti; Megan Krumpoch; Gabriel Fox; Sangkeun Son; Dorota Klepacki; Yury S Polikanov; Cecily A Freliech; Julie E McCarthy; Diane G Edmondson; Steven J Norris; Anthony D'Onofrio; Linden T Hu; Helen I Zgurskaya; Kim Lewis
Journal:  Cell       Date:  2021-10-06       Impact factor: 66.850

4.  Natural killer cell counts are not different between patients with post-Lyme disease syndrome and controls.

Authors:  Adriana Marques; Margaret R Brown; Thomas A Fleisher
Journal:  Clin Vaccine Immunol       Date:  2009-06-10

5.  Lyme disease: the next decade.

Authors:  Raphael B Stricker; Lorraine Johnson
Journal:  Infect Drug Resist       Date:  2011-01-07       Impact factor: 4.003

6.  Deep phenotyping of T cell populations under long-term treatment of tacrolimus and rapamycin in patients receiving renal transplantations by mass cytometry.

Authors:  Yiyang Li; Huimin An; Chuan Shen; Boqian Wang; Ting Zhang; Yifan Hong; Hui Jiang; Peijun Zhou; Xianting Ding
Journal:  Clin Transl Med       Date:  2021-11

Review 7.  Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease.

Authors:  Carolyn M Nielsen; Matthew J White; Martin R Goodier; Eleanor M Riley
Journal:  Front Immunol       Date:  2013-12-09       Impact factor: 7.561

8.  Natural killer cells and natural killer T cells in Lyme arthritis.

Authors:  Kia Katchar; Elise E Drouin; Allen C Steere
Journal:  Arthritis Res Ther       Date:  2013-11-07       Impact factor: 5.156

9.  A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients.

Authors:  Madeleine Morrissette; Norman Pitt; Antonio González; Philip Strandwitz; Mariaelena Caboni; Alison W Rebman; Rob Knight; Anthony D'Onofrio; John N Aucott; Mark J Soloski; Kim Lewis
Journal:  mBio       Date:  2020-09-29       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.